News | October 21, 2015

Arvinas Secures $41.6M Series B Financing – Appoints New Board Members New Haven, CT – October 21, 2015 – Arvinas LLC (“Arvinas”), a private biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that it has closed a...

News | October 21, 2015

RELYPSA ANNOUNCES FDA APPROVAL OF VELTASSA(TM) (PATIROMER) FOR ORAL SUSPENSION FOR THE TREATMENT OF HYPERKALEMIA First new medicine for the treatment of hyperkalemia, or high blood potassium levels, in more than 50 years Approximately 3 million people with chronic...

News | October 21, 2015

Dimension Therapeutics Announces Pricing of Initial Public Offering CAMBRIDGE, MASS, October 21, 2015– Dimension Therapeutics, Inc. (“Dimension” or the “Company”), a leading gene therapy company advancing novel, liver-directed treatments for diverse rare diseases,...

News | October 21, 2015

Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer Former SVP at Millennium/Takeda Fills Newly Created Position to Advance Unum’s Expanding Immunotherapy Clinical Program CAMBRIDGE, MA, October 21, 2015 – Unum...

News | October 21, 2015

Kit Check Adds Children’s Hospital of Orange County as 200th Hospital Customer Washington, DC – Kit Check™ (http://kitcheck.com), the leader in hospital pharmacy kit restocking and medication tracking software, announced that Children’s Hospital of Orange County (CHOC...
felis adipiscing elementum felis dapibus quis in odio